EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities

Khachornsak Seevathee, Pattapong Kessomboon, Nuttaset Manimmanakorn, Suyan Luangphimai, Tewan Thaneerat, Kulthanit Wanaratna, Sirichada Plengphanich, Thanamet Thaenkham, Wijitra Sena

Medical Cannabis and Cannabinoids · 14.11.2024 · 1-24

DOI: 10.1159/000542511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Cannabis and Cannabinoids, online erschienen am 14.11.2024. Verfasst von Khachornsak Seevathee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community, Family and Occupational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic peripheral neuropathy (DPN) represents a prevalent neurological complication affecting millions of patients globally. This clinical investigation evaluated the therapeutic efficacy and safety profile of a novel transdermal medical cannabis formulation (THC:CBD:CBN) in treating painful DPN of the lower extremities.

Methods

This phase III, double-blind, placebo-controlled, randomized clinical trial was conducted at Don Chan Hospital, Thailand, enrolling 100 participants over a 12-week intervention period. Using a computer-generated randomization sequence, participants were allocated to receive either the standardized cannabis formulation or a matched placebo. The primary outcome measure comprised pain intensity assessment using the validated Thai version of the Neuropathic Pain Symptom Inventory (NPSI-T). Secondary outcomes encompassed treatment-emergent adverse events and dermatological manifestations. Statistical analyses were performed using SPSS Version 28.0, incorporating Generalized Estimating Equation (GEE) modeling and Analysis of Covariance (ANCOVA). The study protocol received approval from the Institutional Review Board of Khon Kaen University and the Kalasin Provincial Public Health Office Ethics Committee, with trial registration in the Thai Clinical Trials Registry.

Results

The intervention group demonstrated statistically significant reductions in NPSI-T scores across all measured dimensions (p

Schlagwörter

Stichwörter der Autor:innen

Clinical trialDiabetic peripheral neuropathyPainfulTransdermal medical cannabis

Autor:innen und Institutionen

  • Department of Community, Family and Occupational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Rehabilitation Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Donchan Hospital, Kalasin Provincial Public Health Office, Ministry of Public Health, Kalasin, Thailand.
  • Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Nonthaburi, Thailand.
  • Faculty of Nursing, Khon Kaen University, Khon Kaen, Thailand.

Zitieren

APA

Seevathee, K., Kessomboon, P., Manimmanakorn, N., Luangphimai, S., Thaneerat, T., Wanaratna, K., Plengphanich, S., Thaenkham, T., & Sena, W. (2024). Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities. Medical Cannabis and Cannabinoids, 1-24. https://doi.org/10.1159/000542511

Vancouver

Seevathee K, Kessomboon P, Manimmanakorn N, Luangphimai S, Thaneerat T, Wanaratna K, et al. Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities. Medical Cannabis and Cannabinoids. 2024:1-24. doi:10.1159/000542511

BibTeX
@article{Seevathee2024,
  author = {Seevathee, Khachornsak and Kessomboon, Pattapong and Manimmanakorn, Nuttaset and Luangphimai, Suyan and Thaneerat, Tewan and Wanaratna, Kulthanit and Plengphanich, Sirichada and Thaenkham, Thanamet and Sena, Wijitra},
  title = {Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities},
  journal = {Medical Cannabis and Cannabinoids},
  year = {2024},
  pages = {1--24},
  doi = {10.1159/000542511}
}
Kostenlos starten →